Crescent Biopharma, Inc. (CBIO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Crescent Biopharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.80x | -10.01x | -405.12x | -340.92x | -116.81x | -336.90x |
| P/B Ratio | 0.61x | -31.37x | 389.15x | 370.77x | 90.80x | 134.08x |
| P/S Ratio | 11.39x | 0.00x | 1494882.17x | 212225.94x | 6388.59x | 1691.55x |
| Profitability | ||||||
| Gross Margin | 100.0% | 0.0% | 100.0% | 100.0% | 100.0% | 0.0% |
| Operating Margin | -1407.5% | 0.0% | -392752.9% | -63204.4% | -5470.7% | -506.8% |
| Net Margin | -1419.6% | 0.0% | -368994.2% | -62251.7% | -5469.0% | -502.1% |
| EBITDA Margin | -1380.2% | 0.0% | -391213.5% | -62927.6% | -5447.9% | -504.2% |
| Liquidity | ||||||
| Current Ratio | 6.56x | 3.62x | 6.41x | 5.71x | 7.68x | 11.13x |
| Quick Ratio | 6.56x | 3.62x | 6.41x | 5.71x | 7.68x | 11.13x |
| Leverage | ||||||
| Debt/Equity | 0.01x | -2.42x | 0.02x | 0.02x | 0.02x | 0.02x |
YoY = year-over-year change. Source: FMP..